Yi Lun

机构：Shenzhen University, Shenzhen University Health Science Center

发表论文 38 篇 · 总被引 869 次 · h-index 12

代表论文

• Lysosomal Dysfunction in a Mouse Model of Sandhoff Disease Leads to Accumulation of Ganglioside-Bound Amyloid-β Peptide (2012 · Journal of Neuroscience · 被引 104)
• The Pharmacological Chaperone AT2220 Increases Recombinant Human Acid α-Glucosidase Uptake and Glycogen Reduction in a Mouse Model of Pompe Disease (2012 · PLoS ONE · 被引 83)
• Improved efficacy of a next-generation ERT in murine Pompe disease (2019 · JCI Insight · 被引 82)
• Nanobody Conjugates for Targeted Cancer Therapy and Imaging (2021 · Technology in Cancer Research & Treatment · 被引 59)
• The Pharmacological Chaperone AT2220 Increases the Specific Activity and Lysosomal Delivery of Mutant Acid Alpha-Glucosidase, and Promotes Glycogen Reduction in a Transgenic Mouse Model of Pompe Disease (2014 · PLoS ONE · 被引 39)
• Coformulation of a Novel Human α -Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice (2015 · Molecular Therapy · 被引 37)